StockWatch
·
Pharmaceuticals
Dividend26 May 2026, 05:41 pm

P&G Health Recommends ₹45 Dividend for FY26

AI Summary

Procter & Gamble Health Ltd's board has recommended a final dividend of ₹45 per equity share (Nominal Value of ₹10/- each) for the financial year ended March 31, 2026, subject to shareholder approval. The dividend is to be paid on or before September 25, 2026. The board also approved the audited financial results for FY26, reporting revenue from operations of ₹140797 lakhs and a net profit of ₹32691 lakhs.

Key Highlights

  • P&G Health recommends a final dividend of ₹45 per share for FY26.
  • Dividend payment is subject to shareholder approval at the AGM.
  • FY26 revenue from operations stood at ₹140797 lakhs.
  • Net profit for FY26 is reported as ₹32691 lakhs.
  • Audited financial results for FY26 were approved by the board.